TITLE

Oxidative status and paraoxonase activity in children with asthma

AUTHOR(S)
Cakmak, Alpay; Zeyrek, Dost; Atas, Ali; Selek, Sahabettin; Erel, Ozcan
PUB. DATE
October 2009
SOURCE
Clinical & Investigative Medicine;Oct2009, Vol. 32 Issue 5, pE327
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To compare paraoxonase activity and changes in oxidative status in asthmatic children and healthy children by determining serum paraoxonase activity and total oxidative status, total antioxidant capacity and lipid hydroperoxidation. Methods: Forty two asthmatic children were compared with 32 healthy children of similar age and sex. To evaluate the paraoxonase and oxidative status, total antioxidant capacity and lipid hydroperoxidation were examined. Serum paraoxonase activity was evaluated by measuring the rate of paraoxon hydrolosis. Oxidative status was evaluated by the method developed by Erel. Lipid hydroperoxide was measured by an iodometric method. Results: In comparison with the healthy control group, the paraoxonase activity of the asthmatic children was found to be low (163.7 ± 73.0 (U/L) and 349.2 ± 153.9 (U/L), P = 0.002) and total oxidant status (9.0 ± 3.5 μmol H2O2 Eq/L and 13.4 ± 7.0 μmol H2O2 Eq/L, P =0.002), total antioxidant capacity (5.5 ± 2.5 μmol Trolox Eq/L and 1.0 ± 0.6 μmol Trolox Eq/L, P < 0.001), and lipid hydroperoxidation values (9.9 ± 3.4 μmol H2O2 Eq/L and 4.4 ± 1.5 μmol H2O2 Eq/L, P < 0.001) were found to be high. The high density lipoprotein (HDL) concentration of the asthmatic children was lower than that in the control group (40.1 ± 9.2 mg/dl and 54.5 ± 15.9 mg/dl, P < 0.001) Conclusion: In asthmatic children, when total oxidant status, total antioxidant capacity and lipid hydroperoxidation levels increase, paraoxonase activity decreased.
ACCESSION #
44809932

 

Related Articles

  • ESTABLISHMENT OF PARAOXONASE AND ARYLESTERASE ACTIVITY OF PARAOXONASE 1 (PON1) IN DEPENDENCE ON 55(L/M) AND 192(Q/R) DNA POLYMORPHISM IN ADULT PEOPLE WITH DOWN SYNDROME. SÝ;KORA, Pavel; REPISKÁ, Vanda; SHUSTROVÁ, Mária; HALCHÁK, Lukách // Journal of Special Education & Rehabilitation;2010, Issue 1/2, p103 

    Human serum paraoxonase 1 is a calcium-dependent esterase located on high density lipoproteins (HDL). It inhibits LDL peroxidation and hydrolysis of oxide forms of phospholipides and therefore significantly affects the development of ateroscletosis. The aim of this study was to establish the...

  • Biochemical, Environmental, and Genetic Factors Associated with Paraoxonase (PON1) Activity. Sirivarasai, Jintana; Kaojarern, Sming; Sura, Thanyachai; Yoovathaworn, Krongtong // Biochemical Genetics;Jun2011, Vol. 49 Issue 5/6, p364 

    No abstract available.

  • Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases. Litvinov, Dmitry; Mahini, Halleh; Garelnabi, Mahdi // North American Journal of Medical Sciences;Nov2012, Vol. 4 Issue 11, p523 

    Paraoxonase 1 (PON1) is a hydrolytic enzyme with wide range of substrates, and capability to protect against lipid oxidation. Despite of the large number of compounds that can be hydrolyzed by paraoxonase, the biologically relevant substrates are still not clearly determined. There is a massive...

  • Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease. Hampe, Mahesh Harishchandra; Mogarekar, Mukund Ramchandra // Indian Journal of Human Genetics;Jan-Mar2014, Vol. 20 Issue 1, p51 

    AIMS AND OBJECTIVES: The present study was evaluated the atheroprotective potential of paraoxonase1 (PON1) and its Q192R polymorphism, to determine whether this polymorphism, which is responsible for differential PON1 activity plays any role in the pathogenesis, severity and extent of coronary...

  • Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners? Davis, Kimberly A.; Crow, J. Allen; Chambers, Howard W.; Meek, Edward C.; Chambers, Janice E. // Environmental Health Perspectives;Aug2009, Vol. 117 Issue 8, p1226 

    Background: The southern United States (excluding Florida) has the highest age-adjusted rate of cardiovascular disease (CVD) in the country, with African Americans having a higher prevalence of CVD than Caucasians. Paraoxonase-1 (PON1), an enzyme associated with high-density lipoprotein...

  • Paraoxonase-1 L55M polymorphism with fatty acid composition of phospholipids in high-density lipoproteins. Samani, Keihan Ghatreh; Farrokhi, Effat; Chaleshtory, Morteza Hashemzadeh; Azadegan, Fatemeh // Tehran University Medical Journal;Apr2012, Vol. 70 Issue 1, p7 

    Background: Paraoxonase-1 (PON1) moves with high-density lipoprotein (HDL) particles in blood and prevents low-density lipoprotein (LDL) particles from oxidation. The aims of this study were to investigate the correlation between fatty acid composition of HDL phospholipids with pon-1...

  • Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus. Bahrehmand, Fariborz; Vaisi-Raygani, Asad; Ahmadi, Reza; Kiani, Amir; Rahimi, Zohreh; Tavilani, Haidar; Pourmotabbed, Tayebeh // Iranian Journal of Allergy, Asthma & Immunology;Sep2013, Vol. 12 Issue 3, p211 

    Paraoxonase-1 (PON1) is a serum HDL-bound enzyme that hydrolyzes a number of aromatic carboxylic acid esters including lipid peroxides, preventing LDL oxidation. Systemic lupus erythematosus (SLE) patients are at greater risk of oxidative stress, which is associated with abnormal plasma lipid...

  • 3-D STRUCTURE OF SERUM PARAOXONASE 1 SHEDS LIGHT ON ITS ACTIVITY, STABILITY, SOLUBILITY AND CRYSTALLIZABILITY. Harel, Michal; Brumstein, Boris; Meged, Ran; Dvir, Hay; Ravelli, Raimond B. G.; McCarthy, Andrew; Toker, Lilly; Silman, Israel; Sussman, Joel L. // Archives of Industrial Hygiene & Toxicology / Arhiv za Higijenu ;Sep2007, Vol. 58 Issue 3, p347 

    Serum paraoxonases (PONs) exhibit a wide range of physiologically important hydrolytic activities, including drug metabolism and detoxification of nerve gases. PON1 and PON3 reside on high-density lipoprotein (HDL) (the "good cholesterol"), and are involved in the alleviation of atherosclerosis....

  • Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity. Camps, Jordi; Marsillach, Judit; Joven, Jorge // Mini Reviews in Medicinal Chemistry;Jul2009, Vol. 9 Issue 8, p911 

    Paraoxonase-1 is a lactonase and an esterase and it plays a protective role in toxicity as well as in diseases involving oxidative stress. Recently, insights into how it may be modulated by environmental factors have acquired clinical relevance. This article reviews the state-of-the-art evidence...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics